Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000571139 | SCV000669842 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001433571 | SCV001636362 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-10-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004001040 | SCV004826261 | likely benign | Lynch syndrome | 2023-05-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248284 | SCV005898678 | benign | Lynch syndrome 1 | 2024-12-03 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |